iSpecimen (NASDAQ:ISPC) Posts Earnings Results, Beats Expectations By $0.09 EPS

iSpecimen (NASDAQ:ISPC) posted its quarterly earnings results on Tuesday. The company reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.28) by $0.09, Zacks reports. iSpecimen had a negative net margin of 124.84% and a negative return on equity of 105.25%. The business had revenue of $2.86 million for the quarter.

iSpecimen Price Performance

Shares of ISPC stock remained flat at $0.25 during trading hours on Wednesday. The company’s stock had a trading volume of 361,413 shares, compared to its average volume of 2,226,001. iSpecimen has a 52-week low of $0.20 and a 52-week high of $1.52. The company’s fifty day moving average is $0.32 and its 200 day moving average is $0.34. The firm has a market capitalization of $3.27 million, a P/E ratio of -0.20 and a beta of 1.60.

iSpecimen Company Profile

iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.